ArticleBMC cancer2026

Sensitivity of different epidermal growth factor receptor (EGFR) exon 19 deletion subtypes to first-line osimertinib in Chinese non-small cell lung cancer patients.

Dongming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.